Latest Stem cells Stories
NEW YORK, June 13, 2013 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) announced today that Laurie H. Glimcher, MD, Dean of Weill Cornell Medical College, has been elected to the Board of Trustees. (Photo: http://photos.prnewswire.com/prnh/20130613/DC32105 ) Dr. Glimcher is the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College in New York, where she is also Professor of Medicine. In addition, she is Provost for Medical Affairs of Cornell University. Previous...
NEW YORK, June 13, 2013 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) announced today that Jennifer Jones Austin, CEO and Executive Director of the Federation of Protestant Welfare Agencies, has been elected to the Board of Trustees. Ms. Jones Austin has 20 years of leadership experience working for the advancement of underserved children, individuals and families. (Photo: http://photos.prnewswire.com/prnh/20130613/DC32106 ) Ms. Jones Austin also brings a unique patient...
NEW YORK, June 13, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal...
Researchers discover biochemical pathway that links nail growth to fingertip regeneration Mammals possess the remarkable ability to regenerate a lost fingertip, including the nail, nerves and even bone. In humans, an amputated fingertip can sprout back in as little as two months, a phenomenon that has remained poorly understood until now. In a paper published today in the journal Nature, researchers at NYU Langone Medical Center shed light on this rare regenerative power in mammals, using...
Our Lady of Lourdes Medical Center and The Heart House participate in clinical study to determine whether a patient’s own stem cells can relieve chronic chest pain caused by coronary artery disease. Camden, New Jersey (PRWEB) June 12, 2013 Our Lady of Lourdes Medical Center and The Heart House are participating in a clinical study to determine whether a patient’s own (autologous), adult, stem cells are safe and can relieve chronic chest pain caused by coronary artery disease, as well...
Scientists report in the current issue of STEM CELLS Translational Medicine that they are close to developing a new and effective way to treat tooth decay that fully restores the tooth rather than requires it to be filled, capped or extracted. The method, which uses stem cells, could prove especially useful in treating the kinds of cavities leading to that most dreaded and painful procedure — the root canal. Durham, NC (PRWEB) June 12, 2013 Scientists report in the current issue of STEM...
BOSTON, June 12, 2013 /PRNewswire/ -- Scotland's standing as Europe's largest and most highly regarded stem cell research community has been reaffirmed recently by announcements of funding from the UK Medical Research Council (MRC) and the British Heart Foundation to the MRC Centre for Regenerative Medicine (CRM) based at the Edinburgh BioQuarter. As part of a major $25m boost for UK regenerative medicine, the Edinburgh center will play a key role in the development of new...
Developed with Harvard University, TaqMan® hPSC Scorecard(TM) Panel provides a benchmark against which researchers can evaluate pluripotency and potential of cell lines CARLSBAD, Calif., June 12, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today launched the TaqMan® hPSC Scorecard(TM) Panel, a first-of-its-kind characterization assay that establishes a standardized benchmark against which researchers can now evaluate pluripotency and trilineage differentiation...
In the latest issue of STEM CELLS Translational Medicine, a research team reports a new method which involves the creation of a highly stable and sensitive liver stem cell model. Durham, NC (PRWEB) June 11, 2013 The path to bringing a new drug to market is, simply put, a rocky one. Not only is it estimated to take over 12 years at an average price tag running anywhere between US $800 million and US $2 billion, but more often than not the new drug never makes it through the process. But...
As Medical Successes Rise, Laws Increase Funding And Promote Public Awareness NEW YORK, June 11, 2013 /PRNewswire/ -- As researchers continue to discover groundbreaking medical therapies using stem cells from umbilical cord blood, Federal and State governments in the United States are ramping up their efforts to support the cord blood industry and educate parents-to-be about banking their babies' stem cells. The most recent development happened on May 16(th) when the New York State...
